4 July 2013
Arthritis Research UK has awarded £800,000 funding to work on new treatments for serious arthritis pain.
The healthcare research charity is funding the four-year study in the hope of developing treatments for the severe pain suffered by those with osteoarthritis and rheumatoid arthritis.
University College London (UCL) and the Arthritis Research UK Pain Centre at the University of Nottingham will spend be spending the investment on looking at the functions of different molecules and proteins which can often cause crippling pain.
Professor David Walsh, one of the principal investigators in the forthcoming study, said that scientists would be aiming to determine whether specific molecules which convert stimuli into impulses along the nervous system is more common where pain is more severe.
It is hoped that from this, researchers will be able to move towards developing treatments targeted at those molecules.
“This piece of research offers us a better understanding of the pain caused by arthritis and is therefore a hugely exciting study,” said Professor Alan Silman, medical director at Arthritis Research UK.
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.